Concise review: cell therapy and tissue engineering for cardiovascular disease

Yuji Haraguchi1, Tatsuya Shimizu, Masayuki Yamato

  • 1Institute of Advanced Biomedical Engineering and Science, TWIns, Tokyo Women's Medical University, Tokyo, Japan.

Insights

Cell-based regenerative medicine offers a promising new therapy for cardiovascular diseases. Research is advancing, with clinical trials underway for tissue engineering approaches like scaffold-based and cell sheet-based therapies.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • Cardiovascular disease (CVD) is a leading cause of death and illness globally.
  • Current CVD therapies are actively researched and clinically applied.
  • Cell-based regenerative medicine is emerging as a novel therapeutic strategy for CVD.

Purpose of the Study:

  • To review recent advancements in cell sources for cardiovascular regenerative medicine.
  • To summarize current cell-based regenerative therapies for cardiovascular diseases.
  • To highlight tissue engineering approaches and ongoing clinical trials.

Main Methods:

  • Literature review of recent research on cell sources and regenerative therapies for CVD.
  • Focus on scaffold-based and cell sheet-based tissue engineering techniques.
  • Analysis of data from ongoing clinical trials in the field.

Main Results:

  • Identification of various cell sources suitable for cardiovascular regeneration.
  • Demonstration of the potential of tissue engineering in CVD treatment.
  • Confirmation of the initiation and progress of clinical trials.

Conclusions:

  • Cell-based regenerative therapies hold significant promise for treating cardiovascular diseases.
  • Tissue engineering strategies represent the next generation of these therapies.
  • Continued research and clinical trials are crucial for realizing the full potential of regenerative medicine in cardiology.